Healthcare Realty (HR) Latest Stock Analysis Report – Oct 15, 2026, 4:00 PM ET
Updated Oct 15, 2026, 4:00 PM ET
- Closed at $17.36, +1.88% vs the prior close of $17.04.
- Volume 4.90M shares, 1.2x its 50-day average.
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
HR rises 1.9% to $17.36. Closed at $17.36, +1.88% vs the prior close of $17.04. Day range $17.12–$17.46, opened at $17.31.
HR daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 15, 2026 — HR rises 1.9% to $17.36
- Closed at $17.36, +1.88% vs the prior close of $17.04. Day range $17.12–$17.46, opened at $17.31.
- Volume was 4.90M shares, 1.2x its 50-day average of 3.94M.
- Price is -6.3% vs its 50-day average ($18.53) and -7.6% vs its 200-day average ($18.80).
- 52-week range $16.31–$22.04; today's close sits at 18% of that range, 21.2% below the 52-week high.
Oct 14, 2026 — HR dips 1.0% to $17.04
- Closed at $17.04, -1.05% vs the prior close of $17.22. Day range $16.93–$17.23, opened at $17.20.
- Volume was 5.76M shares, 1.5x its 50-day average of 3.90M.
- Price is -8.4% vs its 50-day average ($18.59) and -9.3% vs its 200-day average ($18.79).
- 52-week range $16.31–$22.04; today's close sits at 13% of that range, 22.7% below the 52-week high.
Oct 13, 2026 — HR ends flat (+0.1%) to $17.22
- Closed at $17.22, +0.06% vs the prior close of $17.21. Day range $17.09–$17.34, opened at $17.34.
- Volume was 4.47M shares, 1.1x its 50-day average of 3.90M.
- Price is -7.7% vs its 50-day average ($18.66) and -8.4% vs its 200-day average ($18.79).
- 52-week range $16.31–$22.04; today's close sits at 16% of that range, 21.9% below the 52-week high.
Oct 12, 2026 — HR rises 0.3% to $17.21
- Closed at $17.21, +0.35% vs the prior close of $17.15. Day range $16.94–$17.23, opened at $17.12.
- Volume was 2.97M shares, 0.8x its 50-day average of 3.95M.
- Price is -8.1% vs its 50-day average ($18.73) and -8.4% vs its 200-day average ($18.79).
- 52-week range $16.31–$22.04; today's close sits at 16% of that range, 21.9% below the 52-week high.
Oct 9, 2026 — HR ends flat (-0.2%) to $17.15
- Closed at $17.15, -0.23% vs the prior close of $17.19. Day range $17.15–$17.31, opened at $17.21.
- Volume was 4.72M shares, 1.2x its 50-day average of 3.93M.
- Price is -8.8% vs its 50-day average ($18.80) and -8.7% vs its 200-day average ($18.79).
- 52-week range $16.31–$22.04; today's close sits at 15% of that range, 22.2% below the 52-week high.
Oct 8, 2026 — HR rises 1.8% to $17.19 on 2.2x normal volume
- Closed at $17.19, +1.84% vs the prior close of $16.88. Day range $16.83–$17.24, opened at $16.90.
- Volume was 8.50M shares, 2.2x its 50-day average of 3.83M — unusually heavy trading.
- Price is -9.0% vs its 50-day average ($18.89) and -8.5% vs its 200-day average ($18.79).
- 52-week range $16.31–$22.04; today's close sits at 15% of that range, 22.0% below the 52-week high.
Oct 7, 2026 — HR dips 0.9% to $16.88, a 6-month low, 3 down days in a row
- Closed at $16.88, -0.94% vs the prior close of $17.04. Day range $16.87–$17.12, opened at $17.00.
- Volume was 5.02M shares, 1.3x its 50-day average of 3.89M.
- Price is -11.1% vs its 50-day average ($18.98) and -10.1% vs its 200-day average ($18.79).
- 52-week range $16.31–$22.04; today's close sits at 10% of that range, 23.4% below the 52-week high.
- That makes 3 straight losses.
Oct 6, 2026 — HR ends flat (-0.2%) to $17.04, a 6-month low
- Closed at $17.04, -0.23% vs the prior close of $17.08. Day range $16.99–$17.36, opened at $17.11.
- Volume was 5.27M shares, 1.4x its 50-day average of 3.85M.
- Price is -10.7% vs its 50-day average ($19.08) and -9.3% vs its 200-day average ($18.79).
- 52-week range $16.31–$22.04; today's close sits at 13% of that range, 22.7% below the 52-week high.
Oct 5, 2026 — HR dips 2.2% to $17.08, a 6-month low
- Closed at $17.08, -2.23% vs the prior close of $17.47. Day range $17.02–$17.62, opened at $17.47.
- Volume was 6.12M shares, 1.6x its 50-day average of 3.77M.
- Price is -10.9% vs its 50-day average ($19.17) and -9.1% vs its 200-day average ($18.79).
- 52-week range $16.31–$22.04; today's close sits at 13% of that range, 22.5% below the 52-week high.
Oct 2, 2026 — HR ends flat (+0.2%) to $17.47
- Closed at $17.47, +0.23% vs the prior close of $17.43. Day range $17.43–$17.76, opened at $17.49.
- Volume was 3.52M shares, 0.9x its 50-day average of 3.74M.
- Price is -9.3% vs its 50-day average ($19.26) and -7.0% vs its 200-day average ($18.79).
- 52-week range $16.31–$22.04; today's close sits at 20% of that range, 20.7% below the 52-week high.
HR latest news & SEC filings
Every SEC filing by or about HR in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Sep 9, 2026 · 4 — Insider trade report (Form 4)
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Hull Robert E sold 21,000 shares at $19.11 (≈$401.31K) on Sep 8, 2026
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Sep 8, 2026 · 144 — Notice of proposed sale (Form 144)
Notice of proposed sale (Form 144) — an insider or affiliate plans to sell restricted or control shares
A notice of intent, not a completed sale. Any actual sale by a director or officer shows up later on Form 4.
Jul 31, 2026 · S-3 — Shelf registration (S-3)
Shelf registration (S-3) — lets the company sell securities over time
An offering document: new shares or debt may be sold, which can increase the share count (dilution) or debt load. Size and terms are in the prospectus.
Jul 31, 2026 · 8-K — Current report
Current report — a filing companies must make within 4 business days of a major event
- Item 8.01 — Reported other events the company considers important.
Jul 31, 2026 · 424B5 — Prospectus supplement
Prospectus supplement — the company is selling securities off a shelf registration
An offering document: new shares or debt may be sold, which can increase the share count (dilution) or debt load. Size and terms are in the prospectus.
Jul 31, 2026 · S-3ASR — S-3ASR filing
S-3ASR filing
An offering document: new shares or debt may be sold, which can increase the share count (dilution) or debt load. Size and terms are in the prospectus.
Jul 30, 2026 · 10-Q — Quarterly report (unaudited financial statements for the quarter)
Quarterly report (unaudited financial statements for the quarter)
Quarter ended Jun 30, 2026:
- Revenue: $8.03M (prior year $6.98M) (+15.0% vs Jun 30, 2025)
- Net income: -$43.51M (prior year -$157.85M) (loss narrowed vs Jun 30, 2025)
- Diluted EPS: -$0.13 (prior year -$0.45) (loss narrowed vs Jun 30, 2025)
Jul 30, 2026 · 8-K — Current report
Current report — a filing companies must make within 4 business days of a major event
- Item 2.02 — Reported results of operations (earnings release).
- Item 7.01 — Released information under Regulation FD (e.g. a presentation or press release).
This is a results-day filing: the earnings press release is attached as an exhibit.
Jun 23, 2026 · 4 — Insider trade report (Form 4)
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Callaway Amanda L sold 25,767 shares at $20.37 (≈$524.87K) on Jun 23, 2026
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Jun 22, 2026 · 144 — Notice of proposed sale (Form 144)
Notice of proposed sale (Form 144) — an insider or affiliate plans to sell restricted or control shares
A notice of intent, not a completed sale. Any actual sale by a director or officer shows up later on Form 4.
Things to know before you trade HR
- Last results release: Jul 30, 2026 (8-K Item 2.02). Previous ones: Apr 30, 2026, Feb 12, 2026, Oct 30, 2025. Based on that rhythm, the next report is likely around Oct 29, 2026 — an estimate, not a confirmed date.
- How much it moves: over the last 20 sessions the average daily move was 0.85% (largest 2.2%). That is a relatively calm stock.
- Liquidity: about 4.97M shares (≈$86.31M) trade per day on average.
- 52-week position: $17.36 vs a range of $16.31–$22.04 (18% of the range).
- Dividends: last ex-dividend date Aug 11, 2026 ($0.24/share); 4 payments in the past 12 months.
- Splits: none in the last 2 years.
- Insider trades (Form 4, last 12 months, recent 25 shown): 2 open-market buys, 2 sales; latest: Robert E Hull sold 21,000 shares on Sep 8, 2026.
- Latest filings: 8-K Jul 31, 2026; 10-Q Jul 30, 2026; 8-K Jul 30, 2026.
- Share count: 342.72M shares outstanding (Jul 27, 2026), -2.5% vs a year earlier — the company has been reducing its share count.
- Listing: NYSE · industry: Real Estate Investment Trusts.
HR market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 15, 2026 | 17.31 | 17.46 | 17.12 | 17.36 | 4.90M |
| Oct 14, 2026 | 17.20 | 17.23 | 16.93 | 17.04 | 5.76M |
| Oct 13, 2026 | 17.34 | 17.34 | 17.09 | 17.22 | 4.47M |
| Oct 12, 2026 | 17.12 | 17.23 | 16.94 | 17.21 | 2.97M |
| Oct 9, 2026 | 17.21 | 17.31 | 17.15 | 17.15 | 4.72M |
| Oct 8, 2026 | 16.90 | 17.24 | 16.83 | 17.19 | 8.50M |
| Oct 7, 2026 | 17.00 | 17.12 | 16.87 | 16.88 | 5.02M |
| Oct 6, 2026 | 17.11 | 17.36 | 16.99 | 17.04 | 5.27M |
| Oct 5, 2026 | 17.47 | 17.62 | 17.02 | 17.08 | 6.12M |
| Oct 2, 2026 | 17.49 | 17.76 | 17.43 | 17.47 | 3.52M |
| Oct 1, 2026 | 17.64 | 17.73 | 17.25 | 17.43 | 4.63M |
| Sep 30, 2026 | 18.00 | 18.02 | 17.72 | 17.74 | 2.83M |
| Sep 29, 2026 | 17.94 | 18.07 | 17.83 | 17.94 | 3.63M |
| Sep 28, 2026 | 18.12 | 18.20 | 17.97 | 17.98 | 5.15M |
| Sep 25, 2026 | 17.74 | 18.10 | 17.67 | 18.05 | 4.02M |
| Sep 24, 2026 | 18.03 | 18.15 | 17.79 | 17.83 | 5.05M |
| Sep 23, 2026 | 18.09 | 18.17 | 17.95 | 17.96 | 5.17M |
| Sep 22, 2026 | 18.31 | 18.46 | 18.16 | 18.18 | 4.39M |
| Sep 21, 2026 | 18.29 | 18.35 | 18.13 | 18.27 | 5.55M |
| Sep 18, 2026 | 18.27 | 18.31 | 18.13 | 18.26 | 7.77M |
About Healthcare Realty
Healthcare Realty (HR) is listed on the NYSE and classified by the SEC under “Real Estate Investment Trusts”. Its business address is in NASHVILLE, TN. Fiscal year ends December 31. SEC CIK 1360604.
HR board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Thomas N Bohjalian | Director | May 20, 2026 |
| David Henry | Director | May 20, 2026 |
| Constance B Moore | Director | May 20, 2026 |
| Glenn J Rufrano | Director | May 20, 2026 |
| Donald C Wood | Director | May 20, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Amanda L Callaway | SVP & Chief Accounting Officer | Jun 23, 2026 |
| Ryan E. Crowley | EVP and CIO | Feb 17, 2026 |
| Daniel Gabbay | EVP, Chief Financial Officer | Mar 5, 2026 |
| Austen B. Helfrich | EVP and CFO | Jan 5, 2026 |
| Robert E Hull | EVP and COO | Sep 9, 2026 |
| Andrew Edward Loope | EVP, General Counsel | Feb 11, 2026 |
| Peter A Scott | President and CEO | Apr 15, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Sep 8, 2026 | Robert E Hull | Sale | 21,000 | $19.11 |
| Jun 23, 2026 | Amanda L Callaway | Sale | 25,767 | $20.37 |
| Mar 6, 2026 | Thomas N Bohjalian | Buy | 10,000 | $18.09 |
| Mar 4, 2026 | Daniel Gabbay | Buy | 10 | $18.74 |
HR financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Dec 31, 2025 | $28.21M | $-246.07M | -0.71 | $457.10M |
| Dec 31, 2024 | $19.16M | $-654.49M | -1.81 | $501.62M |
| Dec 31, 2023 | $17.45M | $-278.26M | -0.74 | $499.82M |
| Dec 31, 2022 | $13.71M | $40.90M | 0.15 | $272.75M |
| Dec 31, 2021 | $10.29M | $66.66M | 0.45 | $232.63M |
Latest balance sheet: total assets $9.00B, total liabilities $4.73B, cash $18.99M (as of Jun 30, 2026).
HR earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| Jul 30, 2026 | 8-K Item 2.02 (results) | $21.53 |
| Apr 30, 2026 | 8-K Item 2.02 (results) | $18.70 |
| Feb 12, 2026 | 8-K Item 2.02 (results) | $17.49 |
| Oct 30, 2025 | 8-K Item 2.02 (results) | $17.76 |
| Jul 31, 2025 | 8-K Item 2.02 (results) | $15.36 |
| May 1, 2025 | 8-K Item 2.02 (results) | $15.89 |
| Feb 19, 2025 | 8-K Item 2.02 (results) | $16.77 |
| Oct 30, 2024 | 8-K Item 2.02 (results) | $17.63 |
| Oct 29, 2024 | 8-K Item 2.02 (results) | $18.14 |
| Aug 2, 2024 | 8-K Item 2.02 (results) | — |
| Jul 30, 2024 | 8-K Item 2.02 (results) | — |
| May 7, 2024 | 8-K Item 2.02 (results) | — |
Related stocks · Real Estate Investment Trusts
Welltower (WELL)Prologis (PLD)Equinix (EQIX)American Tower (AMT)Simon Property (SPG)Realty Income (O)Digital Realty (DLR)Ventas (VTR)Public Storage (PSA)Crown Castle (CCI)
Popular today
Micron Technology (MU)Spdr S&P 500 Etf (SPY)Nvidia (NVDA)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Intel (INTC)Apple (AAPL)Microsoft (MSFT)Meta Platforms (META)Broadcom (AVGO)Tesla (TSLA)
More on HR
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 15, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.